IRIS UniCatt

Montuschi, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.106
AS - Asia 3.553
EU - Europa 2.923
SA - Sud America 749
AF - Africa 97
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 6
Totale 11.450
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.995
SG - Singapore 1.603
CN - Cina 788
DE - Germania 625
BR - Brasile 586
SE - Svezia 566
VN - Vietnam 414
IT - Italia 374
UA - Ucraina 269
FR - Francia 226
IE - Irlanda 178
GB - Regno Unito 155
ID - Indonesia 118
HK - Hong Kong 116
IN - India 115
FI - Finlandia 113
PL - Polonia 113
TR - Turchia 76
RU - Federazione Russa 72
AR - Argentina 58
BD - Bangladesh 56
JP - Giappone 52
NL - Olanda 52
CA - Canada 49
MX - Messico 38
ZA - Sudafrica 34
AT - Austria 33
BE - Belgio 33
IQ - Iraq 33
EC - Ecuador 26
ES - Italia 23
KR - Corea 22
PK - Pakistan 22
SA - Arabia Saudita 21
CL - Cile 19
CO - Colombia 19
MA - Marocco 16
IR - Iran 15
AU - Australia 14
CH - Svizzera 14
EG - Egitto 11
IL - Israele 11
VE - Venezuela 11
LT - Lituania 10
UZ - Uzbekistan 10
AZ - Azerbaigian 9
PH - Filippine 9
JO - Giordania 8
KE - Kenya 8
PY - Paraguay 8
UY - Uruguay 8
AL - Albania 7
BG - Bulgaria 7
CZ - Repubblica Ceca 7
PE - Perù 7
DZ - Algeria 6
MY - Malesia 6
NP - Nepal 6
PT - Portogallo 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
KZ - Kazakistan 5
OM - Oman 5
PA - Panama 5
RS - Serbia 5
BO - Bolivia 4
EU - Europa 4
KG - Kirghizistan 4
LV - Lettonia 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
IS - Islanda 3
LB - Libano 3
LU - Lussemburgo 3
TT - Trinidad e Tobago 3
AO - Angola 2
BH - Bahrain 2
CI - Costa d'Avorio 2
EE - Estonia 2
GE - Georgia 2
IM - Isola di Man 2
JM - Giamaica 2
KH - Cambogia 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
YE - Yemen 2
BB - Barbados 1
Totale 11.429
Salva come PNG Salva come JPEG
Città #
Singapore 847
Ashburn 497
Chandler 491
San Jose 305
Dublin 173
Beijing 164
San Mateo 147
Ho Chi Minh City 125
Jacksonville 120
Cattolica 114
Hanoi 113
Nanjing 110
Warsaw 109
New York 107
Los Angeles 105
Jakarta 102
Ann Arbor 101
Hong Kong 93
Lauterbourg 90
Bremen 87
Wilmington 84
Boston 76
The Dalles 76
Woodbridge 74
Munich 66
Fairfield 59
Lawrence 55
Redwood City 55
Hefei 54
Frankfurt am Main 52
Moscow 51
Izmir 46
Milan 45
Rome 45
São Paulo 45
Tokyo 44
Dearborn 43
Seattle 43
Dallas 41
Buffalo 40
Houston 39
Princeton 33
Helsinki 32
Boardman 31
Brussels 29
Shanghai 27
Guangzhou 26
Hangzhou 26
Santa Clara 25
Chicago 23
Rio de Janeiro 23
Vienna 23
Paris 22
Nanchang 21
Orem 21
Da Nang 20
Kent 20
Nürnberg 20
Wageningen 20
Cambridge 19
Marseille 19
Montreal 19
Norwalk 19
Columbus 18
Dhaka 18
Johannesburg 18
Mountain View 18
London 17
Redmond 17
Nuremberg 15
Shenyang 15
Fremont 14
Hebei 14
Seoul 14
Tianjin 14
Brooklyn 13
Chennai 13
Mexico City 13
Pune 13
Stockholm 13
Manchester 12
Miami 12
Porto Alegre 12
Turku 12
Zhengzhou 12
Amsterdam 11
Baghdad 11
Changsha 11
Council Bluffs 11
Falls Church 11
Jiaxing 11
Lancaster 11
Toronto 11
Atlanta 10
Biên Hòa 10
Buenos Aires 10
Detroit 10
Düsseldorf 10
Haiphong 10
Mumbai 10
Totale 6.126
Salva come PNG Salva come JPEG
Nome #
Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD 337
Development of a sensing array for human breath analysis based on SWCNT layers functionalized with semiconductor organic molecules 248
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 235
Computed tomography for evaluation of the small airway disease in asthma. 221
Detection and characterization of extracellular vesicles in exhaled breath condensate and sputum of COPD and severe asthma patients 206
Impact of air pollution on respiratory diseases in urban areas: a systematic review 201
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 194
Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease 180
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 180
Development of a Sensing Array for Human Breath Analysis Based on SWCNT Layers Functionalized with Semiconductor Organic Molecules 179
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 176
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 175
Electronic nose and exhaled breath NMR-based metabolomics applications in airways disease 174
Liquid chromatography-mass spectrometry measurement of leukotrienes in asthma and other respiratory diseases 170
Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD 168
Investigational prostaglandin D2 receptor antagonists for airway inflammation 167
Inhaled muscarinic acethylcholine receptor antagonists for treatment of COPD 166
Exploring the performance of a functionalized CNT-based sensor array for breathomics through clustering and classification algorithms: From gas sensing of selective biomarkers to discrimination of chronic obstructive pulmonary disease 162
Dupilumab for the treatment of asthma 152
U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics 147
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 144
NMR spectroscopy-based metabolomics of exhaled breath condensate in inflammatory respiratory diseases 143
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 141
Impulse oscillometry and nitrogen washout test in the assessment of small airway dysfunction in asthma: correlation with quantitative computed tomography 138
Exhaled Nitric Oxide Measurement in Patients Affected by Nasal Polyposis 135
Stratification of asthma phenotypes by airway proteomic signatures 132
Leukotriene modifiers for asthma treatment 131
Gallbladder emptying, plasma levels of estradiol and progesterone, and cholecystokinin secretion in liver cirrhosis 131
NMR-Based Metabolomics for the Assessment of Inhaled Pharmacotherapy in Chronic Obstructive Pulmonary Disease Patients 131
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 130
Severe asthma: One disease and multiple definitions 128
Pharmacotherapy of asthma: regular treatment or on demand? 126
Liquid chromatography/mass spectrometry analysis of exhaled leukotriene B4 in asthmatic children 125
8-isoprostane in exhaled breath condensate after experimental exposure to wood smoke in humans 119
Indirect monitoring of lung inflammation 118
Dupilumab for the treatment of asthma 118
Comparison of classification methods in breath analysis by electronic nose 116
Exhaled and non-exhaled non-invasive markers for assessment of respiratory inflammation in patients with stable COPD and healthy smokers 115
Predictive markers of bronchial hyperreactivity in a large cohort of young adults With cough variant asthma 115
Non-invasive biomarkers of lung inflammation in smoking subjects 114
Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends 114
Novel perspectives in the detection of oral and nasal oxidative stress and inflammation in pediatric united airway diseases 113
Immediate allergic reactions to beta-lactams: diagnosis and therapy. 106
LC/MS/MS analysis of leukotriene B4 in exhaled breath condensate for assessing lung inflammation. 106
The combined impact of exhaled nitric oxide and sputum eosinophils monitoring in asthma treatment: a prospective cohort study 106
IL-17-high asthma with features of a psoriasis immunophenotype 106
Exhaled breath condensate in COPD: application in clinical practice 102
Medication Adherence in Patients With Severe Asthma Prescribed Oral Corticosteroids in the U-BIOPRED Cohort 100
Role of beta-blockers in patients with COPD: current perspective 100
New perspectives in pharmacological treatment of mild persistent asthma 98
8-Isoprostane in exhaled breath condensate and exercise-induced bronchoconstriction in asthmatic children and adolescents. 98
Clinical and inflammatory characteristics of the European U-BIOPRED adult severe asthma cohort 98
Comparison of two exhaled biomarkers in children with and without sleep disordered breathing 97
The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease 97
Long-acting beta-agonists and their association with inhaled corticosteroids in COPD 95
Pharmacotherapy of patients with mild persistent asthma: strategies and unresolved issues 94
Treatable traits in the European U-BIOPRED adult asthma cohorts 94
Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. 93
eNose breath prints as a surrogate biomarker for classifying patients with asthma by atopy 92
Single-inhaler triple therapy utilizing the once-daily combination of fluticasone furoate, umeclidinium and vilanterol in the management of COPD: the current evidence base and future prospects 92
WHITIN-DAY AND BETWEEN-DAY REPEATIBILITY OF MEASURERMENTS WITH AN ELECTRONIC NOSE IN PATIENTS WITH COPD 90
The electronic nose in respiratory medicine. 90
Triple inhaled therapy for chronic obstructive pulmonary disease 90
Metabolomic analysis by nuclear magnetic resonance spectroscopy as a new approach to understanding inflammation and monitoring of pharmacological therapy in children and young adults with cystic fibrosis 89
Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma 88
Urinary metabotype of severe asthma evidences decreased carnitine metabolism independent of oral corticosteroid treatment in the U-BIOPRED study 87
Diagnostic performance of an electronic nose, fractional exhaled nitric oxide, and lung function testing in asthma. 87
Drugs for chronic obstructive pulmonary disease. 87
Exhaled nitric oxide as a biomarker in COPD and related comorbidities 87
Within-day and between-day repeatability of measurements with an electronic nose in patients with COPD 87
Exhaled volatile organic compounds as markers for medication use in asthma 87
Exhaled breath condensate biomarkers of airway inflammation and oxidative stress in COPD 86
Nuclear magnetic resonance-based metabolomics discriminates primary ciliary dyskinesia from cystic fibrosis 86
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis 84
Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project 83
The potential role of endothelial dysfunction and platelet activation in the development of thrombotic risk in COPD patients 83
Lipid phenotyping of lung epithelial lining fluid in healthy human volunteers 82
Sputum proteomic signature of gastro-oesophageal reflux in patients with severe asthma 82
Nuclear magnetic resonance-based metabolomics of exhaled breath condensate: methodological aspects 81
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotyping 81
Transcriptional regulation of kinases downstream of the T cell receptor: another immunomodulatory mechanism of glucocorticoids 81
Separating Smoking-Related Diseases Using NMR-Based Metabolomics of Exhaled Breath Condensate 80
Characteristics and treatment regimens across ERS SHARP severe asthma registries 80
Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study 78
Editorial: Insights in respiratory pharmacology: 2021 77
A European Respiratory Society technical standard: exhaled biomarkers in lung disease 74
High sputum total adiponectin is associated with low odds for asthma. 72
Large-Scale Label-Free Quantitative Mapping of the Sputum Proteome 71
Exhaled breath condensate, nasal eosinophil cationic protein level and nasal cytology during immunotherapy for cypress allergy. 70
The role of inflammation in anxiety and depression in the European U-BIOPRED asthma cohorts 69
Vilanterol trifenatate for the treatment of COPD 69
Exhaled 8-isoprostane and prostaglandin E2 in patients with stable and unstable cystic fibrosis. 68
Mapping atopic dermatitis and anti-IL-22 response signatures to type 2-low severe neutrophilic asthma 68
Epithelial dysregulation in obese severe asthmatics with gastro-oesophageal reflux 65
Enhanced oxidative stress in smoking and ex-smoking severe asthma in the U-BIOPRED cohort 63
Role of beta-blockers in patients with COPD: current perspective 62
Sputum proteomics and airway cell transcripts of current and ex-smokers with severe asthma in U-BIOPRED: an exploratory analysis 61
Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation 57
Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation 53
Asthma similarities across ProAR (Brazil) and U-BIOPRED (Europe) adult cohorts of contrasting locations, ethnicity and socioeconomic status 51
Totale 11.475
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.258
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021183 0 0 0 0 0 0 0 0 0 49 117 17
2021/2022868 57 64 22 68 66 35 22 138 39 46 173 138
2022/20231.633 201 215 131 277 133 226 48 125 186 17 45 29
2023/2024815 34 248 17 113 26 104 56 10 7 39 64 97
2024/20251.555 32 50 124 54 121 39 57 54 237 159 352 276
2025/20264.246 713 167 267 456 797 256 915 194 240 241 0 0
Totale 11.612